The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cellsAlejandro Vázquez‐Martín, Javier A. Menéndez|Cell Cycle|2009Cited by 251
Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody TrastuzumabAlejandro Vázquez‐Martín, Javier A. Menéndez|PLoS ONE|2009Cited by 245
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cellsJavier A. Menéndez, Antonio Segura‐Carretero, Alegría Carrasco‐Pancorbo et al.|BMC Cancer|2007Cited by 191
Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cellsJavier A. Menéndez, Rámón Colomer, H. Cortés-Funes et al.|European Journal of Cancer|2001Cited by 145
Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental ValidationElisabet Cuyàs, Javier A. Menéndez|Frontiers in Endocrinology|2018Cited by 122